Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Change in Accured Expenses (2020 - 2026)

Analysis

Starling Oncology (STLN) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 551.00 Mn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn -493.00 Mn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn -22.40 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn -11.42 Mn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 94.87 Mn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 145.62 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 4.48 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 18.28 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn -
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 3.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.44 Mn
Mar 31, 2026 3.92 Mn
Dec 31, 2025 -2.84 Mn
Sep 30, 2025 127,000.00
Jun 30, 2025 -305,000.00
Mar 31, 2025 2.57 Mn
Dec 31, 2024 4.66 Mn
Sep 30, 2024 2.84 Mn
Jun 30, 2024 -3.39 Mn
Mar 31, 2024 5.37 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 -771,000.00
Jun 30, 2023 2.16 Mn
Mar 31, 2023 -805,000.00
Dec 31, 2022 -545,000.00
Sep 30, 2022 332,000.00
Jun 30, 2022 2.04 Mn
Mar 31, 2022 526,000.00
Dec 31, 2021 -4.52 Mn
Sep 30, 2021 -55,000.00